Advance on diagnosis and surgical management of multiple primary non-small cell lung cancers

doi:10.3877/cma.j.issn.2095-8773.2014.01.002

Abstract

Abstract:

With the change of disease spectrum and technology advancement, especially with the screening of early lung cancer, tremendous changes in clinical manifestations have taken place for non-small cell lung cancer (NSCLC), which are characterized by the transformation from central type disease to peripheral type disease, from squamous carcinoma to adenocarcinoma, from massive type to small nodule, and from single lesion to multiple lesions. Multiple-lesion lung cancers may be multiple primary lung cancers or lung metastasis of lung cancer, and the differential diagnosis and prognosis are important factors for management strategies. Through recent literature review, in combination with research findings of these kinds of diseases in this hospital, the diagnosis and surgical management of multiple primary lung cancers are introduced in this paper.

Key words: Carcinoma, non-small cell lung, Diagnosis, Surgical procedures, operative

Haiquan Chen. Advance on diagnosis and surgical management of multiple primary non-small cell lung cancers[J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2014, 01(01): 3-7.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxbwkdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-8773.2014.01.002

https://zhxbwkdzzz.cma-cmc.com.cn/EN/Y2014/V01/I01/3

Figures/Tables 1

References 29

[1]	Gazdar AF, Minna JD. Multifocal lung cancers—clonality vs field cancerization and does it matter？[J] J Natl Cancer Inst，2009，101(8)：541-543.
[2]	Ishigaki T, Yoshimasu T, Oura S, et al. Surgical treatment for metachronous second primary lung cancer after radical resection of primary lung cancer[J]. Ann Thorac Cardiovasc Surg，2013，19(5)：341-344.
[3]	Flieder DB, Vazquez M, Carter D, et al. Pathologic findings of lung tumors diagnosed on baseline CT screening[J]. Am J Surg Patho，2006，30(5)：606-613.
[4]	Tanvetyanon T, Finley DJ, Fabian T, et al. Prognostic factors for survival after complete resections of synchronous lung cancers in multiple lobes: pooled analysis based on individual patient data[J]. Ann Oncol, 2013，24(4)：889-894.
[5]	Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours[J]. J Thorac Oncol, 2007，2(8)：706-714.
[6]	Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin[J]. Cancer，1953；6(5)：963-968.
[7]	Strong MS, Incze J, Vaughan CW. Field cancerization in the aerodigestive tract—its etiology, manifestation, and significance[J]. J Otolaryngol, 1984，13(1)：1-6.
[8]	Johnson BE, Cortazar P, Chute JP. Second lung cancers in patients successfully treated for lung cancer[J]. Semin Oncol，1997，24(4)：492-499.
[9]	Tang X, Shigematsu H, Bekele BN, et al. EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients[J]. Cancer Res，2005，65(17)：7568-7572.
[10]	Wang X, Wang M, MacLennan GT, et al. Evidence for common clonal origin of multifocal lung cancers[J]. J Natl Cancer Inst, 2009，101(8)：560-570.
[11]	Martini N, Melamed MR. Multiple primary lung cancers[J]. J Thorac Cardiovasc Surg, 1975，70(4)：606-612.
[12]	Shen KR, Meyers BF, Larner JM, et al, American College of Chest P. Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)[J]. Chest，2007，132(3 Suppl)：290S-305S.
[13]	Chang YL, Wu CT, Lin SC, et al. Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers[J]. Clin Cancer Res, 2007，13(1)：52-58.
[14]	Girard N, Deshpande C, Azzoli CG, et al. Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines[J]. Chest，2010，137(1)：46-52.
[15]	Arai J, Tsuchiya T, Oikawa M, et al. Clinical and molecular analysis of synchronous double lung cancers[J]. Lung Cancer，2012，77(2)：281-287.
[16]	Takamochi K, Oh S, Matsuoka J, et al. Clonality status of multifocal lung adenocarcinomas based on the mutation patterns of EGFR and K-ras[J]. Lung Cancer, 2012，75(3)：313-320.
[17]	Warth A, Macher-Goeppinger S, Muley T, et al. Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy[J]. Eur Res J, 2012，39(6)：1437-1442.
[18]	Girard N, Deshpande C, Lau C, et al. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases[J]. Am J Surg Pathol, 2009，33(12)：1752-1764.
[19]	Girard N, Ostrovnaya I, Lau C, et al. Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers[J]. Clin Cancer Res，2009，15(16)：5184-5190.
[20]	Matsuzoe D, Hideshima T, Ohshima K，et al. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation[J]. British J Cancer，1999，79(9-10)：1549-1552.
[21]	Murphy SJ, Aubry MC, Harris FR, et al. Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small-cell lung cancer[J]. J Clin Oncol, 2014，32(36)：4050-4058.
[22]	Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib[J]. N Engl J Med, 2004，350(21)：2129-2139.
[23]	Li C, Fang R, Sun Y, et al. Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers[J]. PLoS One, 2011，6(11)：e28204.
[24]	Sun Y, Ren Y, Fang Z, et al. Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases[J]. J Clin Oncol，2010，28(30)：4616-4620.
[25]	Zhang Y, Hu H, Wang R, et al. Synchronous non-small cell lung cancers: diagnostic yield can be improved by histologic and genetic methods[J]. Ann Surg Oncol, 2014，21(13)：4369-4374.
[26]	Yatabe Y, Matsuo K, Mitsudomi T. Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinoma[J]. J Clin Oncol, 2011，29(22)：2972-2977.
[27]	Asamura H. Multiple primary cancers or multiple metastases, that is the question[J]. J Thorac Oncol，2010，5(7)：930-931.
[28]	Kim HK, Choi YS, Kim K, et al. Management of ground-glass opacity lesions detected in patients with otherwise operable non-small cell lung cancer[J]. J Thorac Oncol，2009，4(10)：1242-1246.
[29]	Trousse D, Barlesi F, Loundou A, et al. Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management[J]. J Thorac Cardiovasc Surg, 2007, 133(5): 1193-1200.

Please choose a citation manager

Content to export